299 related articles for article (PubMed ID: 28302045)
1. Complications Following Stem Cell Therapy in Inflammatory Bowel Disease.
Wei H; Liu X; Ouyang C; Zhang J; Chen S; Lu F; Chen L
Curr Stem Cell Res Ther; 2017; 12(6):471-475. PubMed ID: 28302045
[TBL] [Abstract][Full Text] [Related]
2. The role of mesenchymal stem cells in hematopoietic stem cell transplantation: prevention and treatment of graft-versus-host disease.
Zhao L; Chen S; Yang P; Cao H; Li L
Stem Cell Res Ther; 2019 Jun; 10(1):182. PubMed ID: 31227011
[TBL] [Abstract][Full Text] [Related]
3. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
Talmadge JE
Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
[TBL] [Abstract][Full Text] [Related]
4. Review article: mesenchymal stromal cell therapy for inflammatory bowel diseases.
Grégoire C; Lechanteur C; Briquet A; Baudoux É; Baron F; Louis E; Beguin Y
Aliment Pharmacol Ther; 2017 Jan; 45(2):205-221. PubMed ID: 27878827
[TBL] [Abstract][Full Text] [Related]
5. Co-transplantation of multipotent mesenchymal stromal cells in allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis.
Kallekleiv M; Larun L; Bruserud Ø; Hatfield KJ
Cytotherapy; 2016 Feb; 18(2):172-85. PubMed ID: 26794711
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal Stem Cell Derived Extracellular Vesicles: A Role in Hematopoietic Transplantation?
De Luca L; Trino S; Laurenzana I; Lamorte D; Caivano A; Del Vecchio L; Musto P
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28486431
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal Stromal Cells in Hematopoietic Stem Cell Transplantation.
Bernardo ME; Locatelli F
Methods Mol Biol; 2016; 1416():3-20. PubMed ID: 27236663
[TBL] [Abstract][Full Text] [Related]
8. Hematopoietic stem cell transplantation practice variation among centers in the Eastern Mediterranean Region (EMRO): Eastern Mediterranean Bone Marrow Transplantation (EMBMT) group survey.
Rasheed W; Ghavamzadeh A; Hamladji R; Ben Othman T; Alseraihy A; Abdel-Rahman F; Elhaddad A; Alabdulaaly A; Dennison D; Ibrahim A; Bazarbachi A; Bekadja MA; Mohamed SY; Adil SN; Ahmed P; Benchekroun S; Ramzi M; Jarrar M; Alimoghaddam K; Hussain F; Hamidieh A; Aljurf M
Hematol Oncol Stem Cell Ther; 2013 Mar; 6(1):14-9. PubMed ID: 23664600
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stromal cells and hematopoietic stem cell transplantation.
Bernardo ME; Fibbe WE
Immunol Lett; 2015 Dec; 168(2):215-21. PubMed ID: 26116911
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulation effects of mesenchymal stromal cells on acute graft-versus-host disease after hematopoietic stem cell transplantation.
Zhao K; Lou R; Huang F; Peng Y; Jiang Z; Huang K; Wu X; Zhang Y; Fan Z; Zhou H; Liu C; Xiao Y; Sun J; Li Y; Xiang P; Liu Q
Biol Blood Marrow Transplant; 2015 Jan; 21(1):97-104. PubMed ID: 25300866
[TBL] [Abstract][Full Text] [Related]
11. The harvest and use of autologous back-up grafts for graft failure or severe GVHD after allogeneic hematopoietic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation.
Stelljes M; van Biezen A; Slavin S; Olavarria E; Clark RE; Nagler A; Koza V; Kienast J; Niederwieser D; de Witte T; Ruutu T;
Bone Marrow Transplant; 2008 Dec; 42(11):739-42. PubMed ID: 18724394
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal Stem Cell as a Potential Therapeutic for Inflammatory Bowel Disease- Myth or Reality?
Adak S; Mukherjee S; Sen D
Curr Stem Cell Res Ther; 2017; 12(8):644-657. PubMed ID: 28914206
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cells for the treatment and prevention of graft-versus-host disease: experiments and practice.
Kim N; Im KI; Lim JY; Jeon EJ; Nam YS; Kim EJ; Cho SG
Ann Hematol; 2013 Oct; 92(10):1295-308. PubMed ID: 23722500
[TBL] [Abstract][Full Text] [Related]
14. Reduced efficacy of mesenchymal stromal cells in preventing graft-versus-host disease in an in vivo model of haploidentical bone marrow transplant with leukemia.
Oviedo A; Yañez R; Colmenero I; Aldea M; Rubio A; Bueren JA; Lamana ML
Cell Transplant; 2013; 22(8):1381-94. PubMed ID: 23044223
[TBL] [Abstract][Full Text] [Related]
15. The Role of Immune and Epithelial Stem Cells in Inflammatory Bowel Disease Therapy.
Binienda A; Ziolkowska S; Hauge IH; Salaga M
Curr Drug Targets; 2020; 21(14):1405-1416. PubMed ID: 32364073
[TBL] [Abstract][Full Text] [Related]
16. [Mesenchymal stem cells for treatment of graft-versus-host disease].
Najima Y
Rinsho Ketsueki; 2017; 58(12):2440-2449. PubMed ID: 29332881
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic hematopoietic stem cell transplantation for multiple myeloma: curative but not the standard of care.
Koehne G; Giralt S
Curr Opin Oncol; 2012 Nov; 24(6):720-6. PubMed ID: 22960558
[TBL] [Abstract][Full Text] [Related]
18. Alterations in the cellular immune compartment of patients treated with third-party mesenchymal stromal cells following allogeneic hematopoietic stem cell transplantation.
Jitschin R; Mougiakakos D; Von Bahr L; Völkl S; Moll G; Ringden O; Kiessling R; Linder S; Le Blanc K
Stem Cells; 2013 Aug; 31(8):1715-25. PubMed ID: 23554294
[TBL] [Abstract][Full Text] [Related]
19. Inducible Costimulator Gene-Transduced Bone Marrow-Derived Mesenchymal Stem Cells Attenuate the Severity of Acute Graft-Versus-Host Disease in Mouse Models.
Yang D; Wang LP; Zhou H; Cheng H; Bao XC; Xu S; Zhang WP; Wang JM
Cell Transplant; 2015; 24(9):1717-31. PubMed ID: 25203502
[TBL] [Abstract][Full Text] [Related]
20. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]